Education
About Us
Working with TipRanks
Follow Us
Ryman Healthcare Ltd. (RHCGF)
OTHER OTC:RHCGF
Total Valuation
Ryman Healthcare has a market cap or net worth of $1.45B. The enterprise value is $2.05B.
Market Cap$1.45B
Enterprise Value$2.05B
Share Statistics
Ryman Healthcare has 1,015,729,060 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,015,729,060
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ryman Healthcare’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -1.06%.
Return on Equity (ROE)-0.10
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-1.06%
Return on Capital Employed (ROCE)-0.01
Revenue Per Employee92.70K
Profits Per Employee0.00
Employee Count7,700
Asset Turnover0.06
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Ryman Healthcare is ―. Ryman Healthcare’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.41
Price to FCF0.00
Price to Operating Cash Flow8.94
PEG Ratio―
Income Statement
In the last 12 months, Ryman Healthcare had revenue of 713.80M and earned -436.83M in profits. Earnings per share was -0.61.
Revenue713.80M
Gross Profit713.80M
Operating Income-118.26M
Pretax Income-215.39M
Net Income-436.83M
EBITDA-27.16M
Earnings Per Share (EPS)-0.61
Cash Flow
In the last 12 months, operating cash flow was 290.35M and capital expenditures -51.21M, giving a free cash flow of 238.94M billion.
Operating Cash Flow290.35M
Free Cash Flow238.94M
Free Cash Flow per Share0.24
Dividends & Yields
Ryman Healthcare pays an annual dividend of $0.056, resulting in a dividend yield of ―
Dividend Per Share$0.056
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.06
52-Week Price Change-44.27%
50-Day Moving Average1.62
200-Day Moving Average1.50
Relative Strength Index (RSI)0.29
Average Volume (3m)50.00
Important Dates
Ryman Healthcare upcoming earnings date is May 15, 2026, TBA (Confirmed).
Last Earnings DateNov 26, 2025
Next Earnings DateMay 15, 2026
Ex-Dividend Date―
Financial Position
Ryman Healthcare as a current ratio of 0.24, with Debt / Equity ratio of 40.41%
Current Ratio0.24
Quick Ratio0.24
Debt to Market Cap0.95
Net Debt to EBITDA-61.78
Interest Coverage Ratio-0.85
Taxes
In the past 12 months, Ryman Healthcare has paid 221.44M in taxes.
Income Tax221.44M
Effective Tax Rate-1.03
Enterprise Valuation
Ryman Healthcare EV to EBITDA ratio is -126.70, with an EV/FCF ratio of 11.36.
EV to Sales4.82
EV to EBITDA-126.70
EV to Free Cash Flow11.36
EV to Operating Cash Flow8.39
Balance Sheet
Ryman Healthcare has $8.85M in cash and marketable securities with $1.70B in debt, giving a net cash position of -$1.65B billion.
Cash & Marketable Securities$8.85M
Total Debt$1.70B
Net Cash-$1.65B
Net Cash Per Share-$1.62
Tangible Book Value Per Share$5.98
Margins
Gross margin is -8.07%, with operating margin of -16.57%, and net profit margin of -61.20%.
Gross Margin-8.07%
Operating Margin-16.57%
Pretax Margin-30.18%
Net Profit Margin-61.20%
EBITDA Margin-3.80%
EBIT Margin-10.59%
Analyst Forecast
The average price target for Ryman Healthcare is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―